Quick Summary:
In an era where the need for non-opioid, effective pain management solutions is increasingly crucial, robust understanding of the global pain management devices market is essential. These devices, ranging from nerve stimulators to analgesic infusion pumps, provide targeted relief for conditions such as cancer pain, neuropathic pain, and more. They work by interfacing directly with the nervous system, facilitating more effective pain relief than traditional, systemic treatments.
This comprehensive report offers in-depth analysis of market dynamics, key player profiles, and detailed segmentation by type, application, and end user. With rising prevalence of neurological illnesses, the pivot toward non-opioid treatments, and the benefits offered by neurostimulation devices, this market is set for significant expansion. The report's insights will enable stakeholders to make informed decisions regarding product launches, marketing tactics, and overall strategic direction within the global pain management devices industry. Equip yourself with the knowledge to navigate this evolving market space successfully.
Pain management devices include those for cancer pain, nociceptive pain, musculoskeletal pain, and others. There are many different kinds of pain treatment equipment on the market, including ablation devices, transcutaneous electrical nerve stimulators, analgesic infusion pumps, and spinal cord stimulators. These devices work by targeting the source of pain and providing relief through various methods, such as blocking pain signals or releasing medication directly to the affected area. It is important to consult with a healthcare professional to determine the best pain management device for individual needs and conditions. Costly and invasive implantable devices should only be utilized as effective treatments when less aggressive and expensive ones have failed to relieve pain and suffering. When used for the correct reasons by the right people, spinal cord stimulation neuromodulates neuropathic pain signals but not nociceptive pain signals. This results in roughly 60-80% long-term pain alleviation in patients who were tested for efficacy.
Market Dynamics
Devices for neuromodulation are primarily used to treat and reduce the symptoms of neurological illnesses', such as pain, epilepsy, tremor, stroke, etc. Additionally, neuromodulation devices are usedto treat a variety of illnesses linked to aging and neurotic conditions. The prevalence of neurological illnesses is increasing, non-opioid treatments are becoming more popular, and neurostimulation devices provide a variety of advantages, all of which contribute to the market's expansion.Key features of the study:
- This report provides an in-depth analysis of the global pain management devices market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, technology advancement, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pain management devices market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Stryker Corporation, Pfizer Inc. (Hospira Inc.), Medtronic Plc, Boston Scientific Corporation, Baxter International Inc., Braun Melsungen AG, Abbott Laboratories, Colfax Corporation (Djo Global LLC), Kimberly-Clark Corporation (Baylis Medical), Johnson & Johnson (Codman and Shurtleff, Inc.), Neuspera Medical, ZetrOZ Systems, Therabody, BioElectronics Corporation, Nevro Corp, Stevanato Group S.p.A., Bexson Biomedical, Inc., SPR Therapeutics, Lumaflex, Saluda Medical Pty Limited, DyAnsys Inc., Pacira BioSciences, Inc., InterSystems, Nalu Medical, Inc., and StimaWELL North America Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global pain management devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts :
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain management devices market.
Detailed Segmentation:
Global Pain Management Devices Market, By Type:
- Neuromodulation & Neurostimulation Devices
- Analgesic Infusion Pumps
- Ablation Devices
Global Pain Management Devices Market, By Application:
- Neuropathic Pain
- Cancer Pain
- Facial & Migraine Pain
- Musculoskeletal Pain
- Others
Global Pain Management Devices Market, By End User:
- Hospitals
- Clinics
- Others
Global Pain Management Devices Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Stryker Corporation
- Pfizer Inc. (Hospira Inc.)
- Medtronic Plc
- Boston Scientific Corporation
- Baxter International Inc.
- Braun Melsungen AG
- Abbott Laboratories
- Colfax Corporation (Djo Global LLC)
- Kimberly-Clark Corporation (Baylis Medical)
- Johnson & Johnson (Codman and Shurtleff, Inc.)
- Neuspera Medical
- ZetrOZ Systems
- Therabody Inc.
- BioElectronics Corporation
- Nevro Corp
- Stevanato Group S.p.A.
- Bexson Biomedical, Inc
- SPR Therapeutics
- Lumaflex
- Saluda Medical Pty Limited
- DyAnsys Inc
- Pacira BioSciences, Inc.
- InterSystems
- Nalu Medical, Inc.
- StimaWELL North America Inc.
Frequently Asked Questions about the Global Pain Management Devices Market
What is the estimated value of the Global Pain Management Devices Market?
What is the growth rate of the Global Pain Management Devices Market?
What is the forecasted size of the Global Pain Management Devices Market?
Who are the key companies in the Global Pain Management Devices Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | July 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 4280.9 Million |
| Forecasted Market Value ( USD | $ 6670 Million |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
Table of Contents
1. Research Objectives and Assumptions
2. Market Overview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Pain Management Devices Market- COVID-19 Impact Analysis
5. Global Pain Management Devices Market, By Type, 2018-2030, (US$ Mn)
6. Global Pain Management Devices Market, By Application, 2018-2030, (US$ Mn)
7. Global Pain Management Devices Market, By End User, 2018-2030, (US$ Mn)
8. Global Pain Management Devices Market, By Region, 2018-2030, (US$ Mn)
9. Competitive Landscape
10. Section
Companies Mentioned
A selection of companies mentioned in this report includes:
- Stryker Corporation
- Pfizer Inc. (Hospira Inc.)
- Medtronic Plc
- Boston Scientific Corporation
- Baxter International Inc.
- Braun Melsungen AG
- Abbott Laboratories
- Colfax Corporation (Djo Global LLC)
- Kimberly-Clark Corporation (Baylis Medical)
- Johnson & Johnson (Codman and Shurtleff, Inc.)
- Neuspera Medical
- ZetrOZ Systems
- Therabody Inc.
- BioElectronics Corporation
- Nevro Corp
- Stevanato Group S.p.A.
- Bexson Biomedical, Inc
- SPR Therapeutics
- Lumaflex
- Saluda Medical Pty Limited
- DyAnsys Inc
- Pacira BioSciences, Inc.
- InterSystems
- Nalu Medical, Inc.
- StimaWELL North America Inc.
